Literature DB >> 9051023

Changes in contrast enhancement of hepatocellular carcinoma and liver: effect of temporary occlusion of a hepatic vein evaluated with spiral CT.

S Murata1, Y Itai, M Satake, M Asato, H Kobayashi, N Eguchi, N Moriyama.   

Abstract

PURPOSE: To assess the hemodynamics of the liver and of hepatocellular carcinomas (HCCs) with hepatic vein occlusion.
MATERIALS AND METHODS: Selected hepatic veins were temporarily occluded with a balloon catheter in 21 patients with 28 nontreated nodular HCCs. Computed tomographic (CT) arteriography was performed without and with temporary occlusion of a hepatic vein that drained the blood from segmental liver parenchyma containing tumor by using a unified spiral CT and angiography system. The degree of enhancement and change in appearance of the HCC in each condition were compared.
RESULTS: All HCCs were well-enhanced, almost round masses at CT arteriography. At CT arteriography with hepatic vein occlusion, however, HCCs were changed as follows: (a) the absolute attenuation of the HCC was decreased in 27 (96%) of 28 tumors compared with that at CT arteriography without hepatic vein occlusion, while attenuation of the surrounding liver parenchyma was increased; (b) the size of the highly enhanced area in HCC became smaller in 17 (61%) tumors (of these, two disappeared); and (c) the shape was changed in 12 (43%) tumors.
CONCLUSION: Hepatic vein occlusion resulted in reciprocal hemodynamic changes in the liver parenchyma relative to HCCs: Enhancement of the liver increases and that of HCCs decreases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051023     DOI: 10.1148/radiology.202.3.9051023

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Retrograde-outflow percutaneous isolated hepatic perfusion using cisplatin: A pilot study on pharmacokinetics and feasibility.

Authors:  Satoru Murata; Shiro Onozawa; Takahiko Mine; Tatsuo Ueda; Fumie Sugihara; Daisuke Yasui; Shin-Ichiro Kumita; Mitsuo Satake
Journal:  Eur Radiol       Date:  2014-12-18       Impact factor: 5.315

Review 2.  Interventional treatment for unresectable hepatocellular carcinoma.

Authors:  Satoru Murata; Takahiko Mine; Fumie Sugihara; Daisuke Yasui; Hidenori Yamaguchi; Tatsuo Ueda; Shiro Onozawa; Shin-ichiro Kumita
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 3.  Transcatheter arterial chemoembolization based on hepatic hemodynamics for hepatocellular carcinoma.

Authors:  Satoru Murata; Takahiko Mine; Tatsuo Ueda; Ken Nakazawa; Shiro Onozawa; Daisuke Yasui; Shin-ichiro Kumita
Journal:  ScientificWorldJournal       Date:  2013-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.